GGrantIndex
Sort

46,585 grants matching heart failure

Localized Targeting of Matrix Proteases Following Myocardial Infarction

$484,492
Francis G Spinale · University Of South Carolina At Columbia · R01 · FY2015 · HL

Overcoming Barries to Mixed-chimerism Induced Tolerance

$484,491
James S. Allan · Massachusetts General Hospital · P01 · FY2012 · HL

Thrombospondin 4 regulates adaptive ER stress response

$484,444
Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · HL

Adenoviral Gene Transfer of Ca2+ ATPase in Heart Failure

$484,400
Massachusetts General Hospital · R01 · FY2004 · HL

Multi-center Randomized Controlled Trial of Refeeding in Anorexia Nervosa

$484,383
Andrea K Garber · University Of California, San Francisco · R01 · FY2015 · HD

Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart

$484,307
Henry M Colecraft · Columbia University Health Sciences · P01 · FY2025 · HL

Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart

$484,307
Henry M Colecraft · Columbia University Health Sciences · P01 · FY2023 · HL

Patient Navigators: Secondary Prevention in Underserved Coronary Disease Patients

$484,274
Diane M Becker · Johns Hopkins University · R01 · FY2007 · NR

Molecular mechanisms of sympatho-excitation in cardiovascular disease

$484,266
Elizabeth Akin · University Of Nevada Reno · R01 · FY2024 · HL

Racial and Ethnic Health Disparities Due to Ambulance Diversion

$484,254
Amresh D Hanchate · Boston Medical Center · R01 · FY2017 · HL

Molecular Imaging of Cardiac Pluripotent Stem Cells

$484,238
Joseph C Wu · Stanford University · R01 · FY2017 · HL

Cardiac Myosin Binding Protein-C in Development and Reversal of Heart Failure

$484,193
Carl Wei-Chan Tong · Texas A&M University Health Science Ctr · R01 · FY2020 · HL

Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity

$484,158
Steven William Hetts · University Of California, San Francisco · R01 · FY2019 · CA

Role of Redox-Mediated Activation of NFkappaB and AP-1 in Neurogenic Hypertension

$484,137
Robin L. Davisson · Cornell University · R01 · FY2009 · HL

Regulation of the mitochondrial calcium uniporter

$483,980
Dipayan Chaudhuri · University Of Utah · R01 · FY2023 · HL

Short-course Benznidazole Treatment to Reduce Trypanosoma cruzi Parasitic Load in Women of Reproductive Age: A Non-inferiorityRandomized Controlled Trial

$483,969
Pierre Buekens · Tulane University Of Louisiana · R01 · FY2021 · HD

HLS16-07: Manufacturing Tissue Engineered Patch to Treat Heart Failure

$483,960
Steven Goldman · Avery Therapeutics, Inc. · R43 · FY2016 · HL

Hyperglycemia, Aldose Reductase and Murine Atherosclerosis

$483,947
Ira Jay Goldberg · Columbia University Health Sciences · P01 · FY2010 · HL

Mechanisms of Congenital Heart Valve Disease

$483,910
Katherine E Yutzey · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL

Mechanisms of Congenital Heart Valve Disease

$483,910
Katherine E Yutzey · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL

Non-Invasive Multi-Modal Neuromonitoring in Adults Undergoing Extracorporeal Membrane Oxygenation

$483,910
Regine Choe · University Of Rochester · R01 · FY2024 · NS

Mechanisms of Congenital Heart Valve Disease

$483,910
Katherine E Yutzey · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · HL

Mechanisms of Congenital Heart Valve Disease

$483,910
Katherine E Yutzey · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · HL

AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES

$483,893
Robert B Banzett · Beth Israel Deaconess Medical Center · R01 · FY2012 · NR

Mechanisms of Synaptic Homeostasis Governing Pre-Sympathetic Neurons in the Hypothalamic Paraventricular Nucleus

$483,891
Glenn M Toney · University Of Texas Hlth Science Center · R01 · FY2020 · NS